1 Min Read
Jan 30 (Reuters) - Achaogen Inc:
* SAYS FDA CLASSIFIED OUTCOME OF ITS Q4 2017 REINSPECTION OF PFIZER’S MCPHERSON FACILITY AS VOLUNTARY ACTION INDICATED Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.